005690.KS
Pharmicell Co., Ltd.
KSC · Healthcare · Biotechnology · KR
KRW 10,380.00
−1.61%Forward multiples
Based on analyst estimates
- P/E forward
- 20.35x
- P/E 2026E
- 10.64x
- P/E 2027E
- 8.60x
- P/E 2028E
- —
- P/S forward
- 7.18x
Trailing multiples
Trailing twelve months
- P/E TTM
- 13.38x
- PEG TTM
- 0.27x
- Price / book
- 4.34x
- Price / sales
- 4.58x
- Price / cash flow
- 15.18x
Enterprise value
- Enterprise value
- KRW 582.7B
- EV / sales
- 4.29x
- EV / EBITDA
- 12.40x
- EV / EBIT
- 13.24x
- Market cap
- KRW 622.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026